Class B1 GPCR activation by an intracellular agonist
Kazuhiro Kobayashi,
Kouki Kawakami,
Tsukasa Kusakizako,
Atsuhiro Tomita,
Michihiro Nishimura,
Kazuhiro Sawada,
Hiroyuki H. Okamoto,
Suzune Hiratsuka,
Gaku Nakamura,
Riku Kuwabara,
Hiroshi Noda,
Hiroyasu Muramatsu,
Masaru Shimizu,
Tomohiko Taguchi,
Asuka Inoue (),
Takeshi Murata () and
Osamu Nureki ()
Additional contact information
Kazuhiro Kobayashi: The University of Tokyo
Kouki Kawakami: Tohoku University
Tsukasa Kusakizako: The University of Tokyo
Atsuhiro Tomita: The University of Tokyo
Michihiro Nishimura: The University of Tokyo
Kazuhiro Sawada: The University of Tokyo
Hiroyuki H. Okamoto: The University of Tokyo
Suzune Hiratsuka: Tohoku University
Gaku Nakamura: Tohoku University
Riku Kuwabara: Tohoku University
Hiroshi Noda: Chugai Pharmaceutical
Hiroyasu Muramatsu: Chugai Pharmaceutical
Masaru Shimizu: Chugai Pharmaceutical
Tomohiko Taguchi: Tohoku University
Asuka Inoue: Tohoku University
Takeshi Murata: Chiba University
Osamu Nureki: The University of Tokyo
Nature, 2023, vol. 618, issue 7967, 1085-1093
Abstract:
Abstract G protein-coupled receptors (GPCRs) generally accommodate specific ligands in the orthosteric-binding pockets. Ligand binding triggers a receptor allosteric conformational change that leads to the activation of intracellular transducers, G proteins and β-arrestins. Because these signals often induce adverse effects, the selective activation mechanism for each transducer must be elucidated. Thus, many orthosteric-biased agonists have been developed, and intracellular-biased agonists have recently attracted broad interest. These agonists bind within the receptor intracellular cavity and preferentially tune the specific signalling pathway over other signalling pathways, without allosteric rearrangement of the receptor from the extracellular side1–3. However, only antagonist-bound structures are currently available1,4–6, and there is no evidence to support that biased agonist binding occurs within the intracellular cavity. This limits the comprehension of intracellular-biased agonism and potential drug development. Here we report the cryogenic electron microscopy structure of a complex of Gs and the human parathyroid hormone type 1 receptor (PTH1R) bound to a PTH1R agonist, PCO371. PCO371 binds within an intracellular pocket of PTH1R and directly interacts with Gs. The PCO371-binding mode rearranges the intracellular region towards the active conformation without extracellularly induced allosteric signal propagation. PCO371 stabilizes the significantly outward-bent conformation of transmembrane helix 6, which facilitates binding to G proteins rather than β-arrestins. Furthermore, PCO371 binds within the highly conserved intracellular pocket, activating 7 out of the 15 class B1 GPCRs. Our study identifies a new and conserved intracellular agonist-binding pocket and provides evidence of a biased signalling mechanism that targets the receptor–transducer interface.
Date: 2023
References: Add references at CitEc
Citations: View citations in EconPapers (2)
Downloads: (external link)
https://www.nature.com/articles/s41586-023-06169-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:618:y:2023:i:7967:d:10.1038_s41586-023-06169-3
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/s41586-023-06169-3
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().